Neuroendocrine neoplasms (NENs) are a diverse group of tumors with varying clinical behaviors. Their incidence has risen due to increased awareness, improved diagnostics, and aging populations. The 2019 World Health Organization classification emphasizes integrating radiology and histopathology to characterize NENs and create personalized treatment plans. Imaging methods like CT, MRI, and PET/CT are crucial for detection, staging, treatment planning, and monitoring, but each of them poses different interpretative challenges and none are immune to pitfalls. Treatment options include surgery, targeted therapies, and chemotherapy, based on the tumor type, stage, and patient-specific factors. This review aims to provide insights into the latest developments and challenges in NEN imaging, diagnosis, and management.

Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers / Asmundo, L.; Rizzetto, F.; Blake, M.; Anderson, M.; Mojtahed, A.; Bradley, W.; Shenoy-Bhangle, A.; Fernandez-del Castillo, C.; Qadan, M.; Ferrone, C.; Clark, J.; Ambrosini, V.; Picchio, M.; Mapelli, P.; Evangelista, L.; Leithner, D.; Nikolaou, K.; Ursprung, S.; Fanti, S.; Vanzulli, A.; Catalano, O. A.. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 13:11(2024). [10.3390/jcm13113281]

Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers

Picchio M.;Mapelli P.;
2024-01-01

Abstract

Neuroendocrine neoplasms (NENs) are a diverse group of tumors with varying clinical behaviors. Their incidence has risen due to increased awareness, improved diagnostics, and aging populations. The 2019 World Health Organization classification emphasizes integrating radiology and histopathology to characterize NENs and create personalized treatment plans. Imaging methods like CT, MRI, and PET/CT are crucial for detection, staging, treatment planning, and monitoring, but each of them poses different interpretative challenges and none are immune to pitfalls. Treatment options include surgery, targeted therapies, and chemotherapy, based on the tumor type, stage, and patient-specific factors. This review aims to provide insights into the latest developments and challenges in NEN imaging, diagnosis, and management.
2024
CT
MRI
neuroendocrine neoplasms
PET/CT
PET/MRI
response criteria
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/167416
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact